LINC02891

From LncRNAWiki
Revision as of 13:57, 25 January 2021 by Chang Liu (talk | contribs) (Characteristics)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

The lncRNA LINC02891 regulated by the oncogenic fusion protein might be functionally implicated in the biology of prevalent subtype of human leukemia. [1]

Annotated Information

Name

Approved symbol:LINC02891

Approved name:long intergenic non-protein coding RNA 2891

HGNC ID:HGNC:55221

Alias symbol:lnc-RTN4R-1

RefSeq ID:NR_038460

Characteristics

Please input information here.

Function

LINC02891 might be functionally implicated in the biology of this prevalent subtype of human leukemia.[1].

Regulation

LINC02891 is regulated by the oncogenic fusion protein.[1]

Expression

Sustained inactivation of LINC02891 in ETV6/RUNX1 positive cells caused profound changes in gene expression.[1]

Diseases

Pediatric B-cell precursor acute lymphoblastic leukemia[1]

Labs working on this lncRNA

  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.[1]
  • Center for Medical Genetics, Department of Paediatrics and Genetics, Ghent University Hospital, Ghent, Belgium.[1]
  • Department of Hemato-Oncology, HUDERF, Université Libre de Bruxelles (ULB), Brussels, Belgium.[1]
  • Department of Hematology, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.[1]
  • Department of Hematology, Children's Hospital, Toulouse, France.[1]
  • Department of Hematology, Institut Universitaire de Cancérologie de Toulouse, University Toulouse-III Paul-Sabatier, Toulouse, France.[1]
  • Department of Pediatric Hemato-Oncology, University Hospitals Leuven, Belgium.[1]
  • Laboratory of Pharmaceutical Biotechnology, Department of Pharmaceutics, Ghent University, Ghent, Belgium.[1]

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 Ghazavi F, De Moerloose B, Van Loocke W, Wallaert A, Helsmoortel HH, Ferster A, Bakkus M, Plat G, Delabesse E, Uyttebroeck A, Van Nieuwerburgh F, Deforce D, Van Roy N, Speleman F, Benoit Y, Lammens T, Van Vlierberghe P. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Oncotarget. 2016 Nov 8;7(45):73769-73780. doi: 10.18632/oncotarget.12063.